Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-22

Clinical Trial Update: Bulbicam Validation on Glaucoma- and Cataract Patients

View source ↗

Summary

A completed clinical trial evaluating Bulbicam in patients with glaucoma and cataract, sponsored by Meddoc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bulbicam

Snippet

Sponsor: Meddoc | Conditions: Glaucoma Eye, Cataract | Status: COMPLETED